Welcome to our dedicated page for Cannabist SEC filings (Ticker: CBSTF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cannabist Company Holdings Inc. (CBSTF) files a range of reports and disclosures with the U.S. Securities and Exchange Commission that shed light on its cannabis operations, capital structure and governance. As a British Columbia corporation with U.S. reporting obligations, its SEC filings help investors understand how the company manages its multi-state cultivation, manufacturing and retail footprint.
On this page, you can review current and historical SEC filings for The Cannabist Company, including Form 8-K reports detailing material events. Recent 8-K filings describe equity purchase agreements to sell the company’s Virginia subsidiary, Green Leaf Medical of Virginia, LLC, first to Curaleaf, Inc. and later to an entity affiliated with Millstreet Credit Fund LP, along with the termination of the Curaleaf agreement and related break-up fee. Other 8-Ks discuss the formation of a special committee to review strategic alternatives, the election not to make an interest payment on senior secured notes within the initial due date, and the resulting 30-day grace period under the indenture.
Filings also cover governance and compensation matters, such as board election results at the annual general meeting, the resignation of a co-founder from the Board of Directors, the transition of the Chief Financial Officer to a consulting role, and the adoption of a key employee retention bonus program that replaced a prior transaction bonus plan. These documents provide context on how the company is addressing leadership continuity and retention during its strategic review.
In addition to event-driven 8-Ks, investors can access quarterly and annual reports referenced in the company’s press releases. These filings include discussions of revenue, margins, non-GAAP measures such as Adjusted EBITDA and Adjusted Gross Profit, and risk factors related to cannabis regulation, taxation and financing.
Stock Titan’s platform presents these filings with AI-powered summaries that highlight key terms, transaction structures, grace periods, and board or executive changes. Real-time updates from EDGAR, along with structured access to material contracts and event disclosures, help users quickly identify developments affecting The Cannabist Company’s notes, asset sales, governance and strategic alternatives.
The Cannabist Company Holdings Inc. entered into an amended arrangement with the holders of its 9.25% Senior Secured Notes due December 31, 2028 and its 9.00% Senior Secured Convertible Notes due December 31, 2028. These noteholders agreed to extend their forbearance agreement and refrain from exercising rights and remedies under the governing indenture and applicable law until March 6, 2026.
The company emphasizes that statements about plans, strategies and future events are forward-looking and subject to significant risks and uncertainties, directing investors to its Form 10-K for the year ended December 31, 2024 and Form 10-Q for the quarter ended September 30, 2025 for detailed risk factors.
The Cannabist Company Holdings Inc. entered into a further agreement with an ad hoc group of holders of its 9.25% Senior Secured Notes due December 31, 2028 and its 9.00% Senior Secured Convertible Notes due December 31, 2028. These noteholders agreed to extend their forbearance from exercising rights and remedies under the governing indenture and applicable law until February 27, 2026. This short-term extension gives the company additional time while it addresses its obligations under these senior secured notes.
The Cannabist Company Holdings Inc. disclosed that an ad hoc group of holders of its 9.25% Senior Secured Notes due December 31, 2028 and 9.00% Senior Secured Convertible Notes due December 31, 2028 has agreed to extend a forbearance arrangement.
These noteholders, party to a previously announced forbearance agreement, will continue to refrain from exercising rights and remedies under the governing indenture and applicable law until February 20, 2026. The company also includes standard forward-looking statement language, directing readers to risk factors in its Form 10-K for 2024 and Form 10-Q for the quarter ended September 30, 2025.
The Cannabist Company Holdings Inc. completed the sale of all equity interests in its Virginia cannabis subsidiary to an affiliate of Millstreet Credit Fund LP for total consideration of
The Virginia business comprises 5 operating retail locations, 1 additional store in development, and about 82,000 square feet of cultivation and production capacity in the Richmond area. In anticipation of closing, the company initiated partial redemptions of its 9.25% Senior Secured Notes and 9.00% Senior Secured Convertible Notes.
The company expects to redeem on February 13, 2026,
The Cannabist Company Holdings Inc. disclosed that it did not make the interest payments due December 31, 2025 on its 9.25% Senior Secured Notes and 9.00% Senior Secured Convertible Notes, leading to an event of default after a 30‑day grace period under the indenture.
On January 30, 2026, the company entered into a forbearance agreement with an ad hoc group of noteholders holding more than 75% of the Notes’ aggregate principal amount. These noteholders agreed to temporarily refrain from enforcing their rights related to the missed interest payments until February 17, 2026, while the company evaluates strategic alternatives, including possible asset sales and other financial or restructuring options.
The Cannabist Company Holdings Inc. plans a conditional partial redemption of its 9.25% Senior Secured Notes due 2028 and 9.00% Senior Secured Convertible Notes due 2028, with total redemption payments capped at $97,000,000.
If a previously announced equity purchase agreement closes on or before February 13, 2026, the company will redeem $84,488,000 principal of the 9.25% Notes and $6,469,000 principal of the 9.00% Convertible Notes, plus accrued interest. If the condition is met after February 13, 2026, the trustee will determine redemption amounts so that payments do not exceed $97,000,000. If the condition is not satisfied within 60 days of January 29, 2026, the redemption notice becomes void.
Bank of Montreal and related entities report a significant ownership position in Cannabist Co Holdings Inc. common stock. As of 09/30/2025, they beneficially own 36,721,908 shares, representing 7.01% of the outstanding common stock.
The group reports sole voting and dispositive power over 4,729,000 shares and shared voting power over 31,992,518 shares. The securities are held in the ordinary course of business, primarily in a prime brokerage capacity on behalf of clients who may receive dividends or sale proceeds. The reporting persons state the holdings are not for the purpose of changing or influencing control of Cannabist and include standard language declining admission that they are part of a coordinated group.
The Cannabist Company Holdings Inc. disclosed that it did not make the interest payment due on its 9.25% Senior Secured Notes due December 31, 2028 and its 9.0% Senior Secured Convertible Notes due December 31, 2028. Under the indenture for these notes, the company has a 30‑day grace period to make the payment before the missed payment becomes an event of default.
The company states it is withholding the payment to enhance short‑term financial flexibility and preserve liquidity while a special committee of independent directors reviews strategic alternatives. That review follows the recently announced sale of its Virginia assets to an affiliate of Millstreet Credit Fund LP and includes possible additional asset sales, mergers, or other strategic, financial or restructuring transactions or proceedings.
The Cannabist Company Holdings Inc. agreed to sell its subsidiary Green Leaf Medical of Virginia, LLC to Parma Holdco LLC for
The Company previously agreed to sell Green Leaf Virginia to Curaleaf, Inc. but terminated that agreement after determining the Parma Holdco proposal was superior. In connection with the termination, the Company must pay Curaleaf a
The Cannabist Company Holdings Inc. approved a new key employee retention bonus plan to support its ongoing strategic review process. The plan replaces a prior transaction-based bonus program and is designed to encourage leaders to stay with the company through critical phases of this review.
The Retention Bonus Plan establishes an aggregate cash bonus pool of approximately $2.74 million for designated employees and officers. Under individual retention agreements, CEO David Hart is eligible for a total cash bonus of $800,000 payable in monthly installments through the last payroll date in November 2026, and President Jesse Channon is eligible for $500,000 payable in monthly installments through the last payroll date in March 2026, subject to continued employment and other conditions.
If an employee is terminated without cause, or in the event of death or disability, any unpaid installments become payable in a lump sum after termination, subject to a release agreement. If employment ends for other reasons, or notice of termination has been given or received before a payment date, remaining unpaid installments are forfeited.